United Therapeutics buy Royal Bank of Canada
Start price
07.07.26
/
50%
€493.50
Target price
07.07.27
€615.51
Performance (%)
-11.14%
Price
08:06
€438.50
Summary
This prediction is currently active. The price of United Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.14%. This prediction currently runs until 07.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -4.378% | -4.378% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€461.70
06.08.26
06.08.26
€586.01
06.08.27
06.08.27
-5.02%
08:06
08:06
United Therapeutics
Start price
Target price
Perf. (%)
€485.40
07.05.26
07.05.26
€596.27
07.05.27
07.05.27
-9.66%
08:06
08:06
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
2.72%
08:06
08:06
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
20.33%
08:06
08:06